Literature DB >> 33397977

Bariatric surgery induces a new gastric mucosa phenotype with increased functional glucagon-like peptide-1 expressing cells.

Lara Ribeiro-Parenti1,2, Anne-Charlotte Jarry1, Jean-Baptiste Cavin1, Alexandra Willemetz1, Johanne Le Beyec1,3, Aurélie Sannier4, Samira Benadda1,5, Anne-Laure Pelletier1, Muriel Hourseau4, Thibaut Léger6,7, Bastien Morlet6, Anne Couvelard1,4, Younes Anini8, Simon Msika1,2, Jean-Pierre Marmuse1,2, Sévérine Ledoux1,9, Maude Le Gall10, André Bado11.   

Abstract

Glucagon-Like Peptide-1 (GLP-1) undergoes rapid inactivation by dipeptidyl peptidase-4 (DPP4) suggesting that target receptors may be activated by locally produced GLP-1. Here we describe GLP-1 positive cells in the rat and human stomach and found these cells co-expressing ghrelin or somatostatin and able to secrete active GLP-1 in the rats. In lean rats, a gastric load of glucose induces a rapid and parallel rise in GLP-1 levels in both the gastric and the portal veins. This rise in portal GLP-1 levels was abrogated in HFD obese rats but restored after vertical sleeve gastrectomy (VSG) surgery. Finally, obese rats and individuals operated on Roux-en-Y gastric bypass and SG display a new gastric mucosa phenotype with hyperplasia of the mucus neck cells concomitant with increased density of GLP-1 positive cells. This report brings to light the contribution of gastric GLP-1 expressing cells that undergo plasticity changes after bariatric surgeries, to circulating GLP-1 levels.

Entities:  

Year:  2021        PMID: 33397977     DOI: 10.1038/s41467-020-20301-1

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  47 in total

Review 1.  The glucagon-like peptides.

Authors:  T J Kieffer; J F Habener
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

Review 2.  Incretin-based therapies for type 2 diabetes mellitus.

Authors:  Julie A Lovshin; Daniel J Drucker
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

3.  Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?

Authors:  N M Whalley; L E Pritchard; D M Smith; A White
Journal:  J Endocrinol       Date:  2011-07-27       Impact factor: 4.286

Review 4.  GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

Authors:  Tanya Hansotia; Daniel J Drucker
Journal:  Regul Pept       Date:  2005-06-15

Review 5.  The physiology of glucagon-like peptide 1.

Authors:  Jens Juul Holst
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

6.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Authors:  B Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.

Authors:  J Schmidtler; K Dehne; H D Allescher; V Schusdziarra; M Classen; J J Holst; A Polack; W Schepp
Journal:  Am J Physiol       Date:  1994-09

8.  Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function.

Authors:  L Gros; F Hollande; B Thorens; A Kervran; D Bataille
Journal:  Eur J Pharmacol       Date:  1995-02-15       Impact factor: 4.432

Review 9.  GLP-1 effects on islets: hormonal, neuronal, or paracrine?

Authors:  Marc Y Donath; Rémy Burcelin
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

10.  Incretin-modulated beta cell energetics in intact islets of Langerhans.

Authors:  David J Hodson; Andrei I Tarasov; Silvia Gimeno Brias; Ryan K Mitchell; Natalie R Johnston; Shahab Haghollahi; Matthew C Cane; Marco Bugliani; Piero Marchetti; Domenico Bosco; Paul R Johnson; Stephen J Hughes; Guy A Rutter
Journal:  Mol Endocrinol       Date:  2014-04-25
View more
  9 in total

1.  GLP-1: 10-year follow-up after Roux-en-Y gastric bypass.

Authors:  Camila Carvalho; Aglécio Luiz de Souza; Gisele Almeida Batista; Louise Franciscato Trivelato Duran; Débora Puzzi Fernandes; Viviane Bressane Claus Molina; Raquel Gonçalves; Joelma Silvia Giorgetti; Elintom Adami Chaim; Sarah Monte Alegre
Journal:  Langenbecks Arch Surg       Date:  2021-10-14       Impact factor: 2.895

2.  Influence of Factors Altering Gastric Microbiota on Bariatric Surgery Metabolic Outcomes.

Authors:  Eduardo García-Fuentes; Francisco J Tinahones; Carolina Gutiérrez-Repiso; Isabel Moreno-Indias; Gracia M Martín-Núñez; Ailec Ho-Plagaro; Luis Ocaña-Wilhelmi; Diego Fernández García; Montserrat Gonzalo Marín; Francisco J Moreno-Ruiz
Journal:  Microbiol Spectr       Date:  2021-11-17

Review 3.  Enteroendocrine System and Gut Barrier in Metabolic Disorders.

Authors:  Céline Osinski; Dounia Moret; Karine Clément; Patricia Serradas; Agnès Ribeiro
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

4.  Altered Glucose Metabolism and Glucose Transporters in Systemic Organs After Bariatric Surgery.

Authors:  Ju Hun Oh; Chan Woo Kang; Eun Kyung Wang; Jung Ho Nam; Soohyun Lee; Kyeong Hye Park; Eun Jig Lee; Arthur Cho; Cheol Ryong Ku
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

Review 5.  The molecular signaling of exercise and obesity in the microbiota-gut-brain axis.

Authors:  Filipe M Ribeiro; Maycon A Silva; Victória Lyssa; Gabriel Marques; Henny K Lima; Octavio L Franco; Bernardo Petriz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

6.  Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats.

Authors:  Ananyaa Sridhar; Dawood Khan; Mahmoud Abdelaal; Jessie A Elliott; Violetta Naughton; Peter R Flatt; Carel W Le Roux; Neil G Docherty; Charlotte R Moffett
Journal:  PLoS One       Date:  2022-09-22       Impact factor: 3.752

Review 7.  GLP-1a: Going beyond Traditional Use.

Authors:  Lucas Fornari Laurindo; Sandra Maria Barbalho; Elen Landgraf Guiguer; Maricelma da Silva Soares de Souza; Gabriela Achete de Souza; Thiago Marques Fidalgo; Adriano Cressoni Araújo; Heron F de Souza Gonzaga; Daniel de Bortoli Teixeira; Thais de Oliveira Silva Ullmann; Katia Portero Sloan; Lance Alan Sloan
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

Review 8.  Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating.

Authors:  Daniel I Brierley; Guillaume de Lartigue
Journal:  Br J Pharmacol       Date:  2021-07-31       Impact factor: 8.739

Review 9.  Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.

Authors:  Eirini Martinou; Irena Stefanova; Evangelia Iosif; Angeliki M Angelidi
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.